{"schema_version":"secwatch.filing_event.v1","accession":"0001999371-24-004225","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2024-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.169560+00:00","generated_at":"2026-06-04T05:18:12.980638+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tonix announces $4.4M offering at $0.30 per share; lowers existing warrant exercise prices to $0.33","bullets":["Gross proceeds of ~$4.4M from sale of 14.7M shares and 14.7M Series E warrants at $0.30 combined price.","Series E warrants exercisable at $0.33, begin 6 months from issuance, expire in 5.5 years.","Existing warrants from Aug/Oct/Dec 2023 amended to exercise price $0.33 and extended expiration dates, subject to shareholder approval.","Proceeds to be used for working capital, general corporate purposes, and to satisfy a portion of debt.","Closing expected April 1, 2024; A.G.P./Alliance Global Partners acts as placement agent with 7% fee."],"urls":{"canonical":"https://secwatch.observer/filing/0001999371-24-004225","json":"https://secwatch.observer/filing/0001999371-24-004225.json","markdown":"https://secwatch.observer/filing/0001999371-24-004225.md","text":"https://secwatch.observer/filing/0001999371-24-004225.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124004225/0001999371-24-004225-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124004225/tnxp_8k-032824.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T05:18:12.980638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9c4cd9d19e72a47ab02811c8d29eb071c6b17725","claim":"Tonix Pharmaceuticals Holding Corp. entered into Purchase Agreement with certain institutional investors valued at up to approximately $4.4 million (effective 2024-03-28).","evidence_excerpt":"On March 28, 2024, Tonix Pharmaceuticals Holding Corp. (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (collectively, the “Purchasers”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124004225/0001999371-24-004225-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors"},{"label":"Value","value":"up to approximately $4.4 million"},{"label":"Effective","value":"2024-03-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}